Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Gallivanone

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Methods and Protocols|October 26, 2022
Radiogenomics, Breast Cancer Diagnosis and Characterization: Current Status and Future DirectionsFrancesca Gallivanone, Gloria Bertoli, Danilo Porro
Current Alzheimer Research|November 17, 2015
Statistical Voxel-Based Methods and [18F]FDG PET Brain Imaging: Frontiers for the Diagnosis of ADFrancesca Gallivanone, Pasquale Anthony Della Rosa, Isabella Castiglioni
Computers in Biology and Medicine|April 6, 2024
Characterization of cell cycle, inflammation, and oxidative stress signaling role in non-communicable diseases: Insights into genetic variants, microRNAs and pathwaysSalvatore D'Antona, Danilo Porro, Francesca Gallivanone, et al.
Frontiers in Bioscience (Landmark Edition)|April 15, 2017
Targeted radionuclide therapy: frontiers in theranosticsFrancesca Gallivanone, Mauro Valente, Annarita Savi, et al.
International Journal of Molecular Sciences|November 24, 2019
<i>In Silico</i> Approach for the Definition of radiomiRNomic Signatures for Breast Cancer Differential DiagnosisFrancesca Gallivanone, Claudia Cava, Fabio Corsi, et al.
Contrast Media & Molecular Imaging|October 3, 2018
Parameters Influencing PET Imaging Features: A Phantom Study with Irregular and Heterogeneous Synthetic LesionsFrancesca Gallivanone, Matteo Interlenghi, Daniela D'Ambrosio, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|December 6, 2014
The impact of different 18FDG PET healthy subject scans for comparison with single patient in SPM analysisFrancesca Gallivanone, Pasquale A Della Rosa, Daniela Perani, et al.
Contrast Media & Molecular Imaging|November 4, 2017
A Method for Manufacturing Oncological Phantoms for the Quantification of 18F-FDG PET and DW-MRI StudiesFrancesca Gallivanone, Irene Carne, Matteo Interlenghi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 12, 2019
AI-based applications in hybrid imaging: how to build smart and truly multi-parametric decision models for radiomicsIsabella Castiglioni, Francesca Gallivanone, Paolo Soda, et al.
Magma (New York, N.Y.)|March 2, 2017
Biomarkers from in vivo molecular imaging of breast cancer: pretreatment <sup>18</sup>F-FDG PET predicts patient prognosis, and pretreatment DWI-MR predicts response to neoadjuvant chemotherapyFrancesca Gallivanone, Marta Maria Panzeri, Carla Canevari, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Methods and Protocols|October 26, 2022
Radiogenomics, Breast Cancer Diagnosis and Characterization: Current Status and Future DirectionsFrancesca Gallivanone, Gloria Bertoli, Danilo Porro
Current Alzheimer Research|November 17, 2015
Statistical Voxel-Based Methods and [18F]FDG PET Brain Imaging: Frontiers for the Diagnosis of ADFrancesca Gallivanone, Pasquale Anthony Della Rosa, Isabella Castiglioni
Computers in Biology and Medicine|April 6, 2024
Characterization of cell cycle, inflammation, and oxidative stress signaling role in non-communicable diseases: Insights into genetic variants, microRNAs and pathwaysSalvatore D'Antona, Danilo Porro, Francesca Gallivanone, et al.
Frontiers in Bioscience (Landmark Edition)|April 15, 2017
Targeted radionuclide therapy: frontiers in theranosticsFrancesca Gallivanone, Mauro Valente, Annarita Savi, et al.
International Journal of Molecular Sciences|November 24, 2019
<i>In Silico</i> Approach for the Definition of radiomiRNomic Signatures for Breast Cancer Differential DiagnosisFrancesca Gallivanone, Claudia Cava, Fabio Corsi, et al.
Contrast Media & Molecular Imaging|October 3, 2018
Parameters Influencing PET Imaging Features: A Phantom Study with Irregular and Heterogeneous Synthetic LesionsFrancesca Gallivanone, Matteo Interlenghi, Daniela D'Ambrosio, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|December 6, 2014
The impact of different 18FDG PET healthy subject scans for comparison with single patient in SPM analysisFrancesca Gallivanone, Pasquale A Della Rosa, Daniela Perani, et al.
Contrast Media & Molecular Imaging|November 4, 2017
A Method for Manufacturing Oncological Phantoms for the Quantification of 18F-FDG PET and DW-MRI StudiesFrancesca Gallivanone, Irene Carne, Matteo Interlenghi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 12, 2019
AI-based applications in hybrid imaging: how to build smart and truly multi-parametric decision models for radiomicsIsabella Castiglioni, Francesca Gallivanone, Paolo Soda, et al.
Magma (New York, N.Y.)|March 2, 2017
Biomarkers from in vivo molecular imaging of breast cancer: pretreatment <sup>18</sup>F-FDG PET predicts patient prognosis, and pretreatment DWI-MR predicts response to neoadjuvant chemotherapyFrancesca Gallivanone, Marta Maria Panzeri, Carla Canevari, et al.
Pageof 4